Sisram Medical Valuation Multiples

Discover revenue and EBITDA valuation multiples for Sisram Medical and similar public comparables like Aroa Biosurgery, Curiosis, CVRx, EKF Diagnostics and more.

Sisram Medical Overview

About Sisram Medical

Sisram Medical Ltd is an investment holding company specializing in medical technology for healthcare. The company is mainly involved in the design, development, manufacture, and sale of energy-based aesthetic medical and minimally invasive treatment systems, non-EBD devices, and cosmeceuticals. The company's products include Soprano Titanium, Colibri technology, and others. Some of the company's brands are Alma, Soprano, Copulla, and LMNT. It operates through the following geographical segments: North America which is its key revenue generating market, Europe, Asia Pacific, Latin America, and the Middle East and Africa.


Founded

2013

HQ

Israel

Employees

1.0K

Financials (LTM)

Revenue: $387M
EBITDA: $37M

EV

$118M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Sisram Medical Financials

Sisram Medical reported last 12-month revenue of $387M and EBITDA of $37M.

In the same LTM period, Sisram Medical generated $226M in gross profit, $37M in EBITDA, and $23M in net income.

Revenue (LTM)


Sisram Medical P&L

In the most recent fiscal year, Sisram Medical reported revenue of $365M and EBITDA of $49M.

Sisram Medical is profitable as of last fiscal year, with gross margin of 59%, EBITDA margin of 13%, and net margin of 5%.

See analyst estimates for Sisram Medical
LTMLast FY202320242025202620272028
Revenue$387M$365M$359M$349M$365M
Gross Profit$226M$215M$220M$217M$215M
Gross Margin58%59%61%62%59%
EBITDA$37M$49M$53M$52M$49M
EBITDA Margin9%13%15%15%13%
EBIT Margin8%9%12%10%9%
Net Profit$23M$19M$31M$25M$19M
Net Margin6%5%9%7%5%

Financial data powered by Morningstar, Inc.

Sisram Medical Stock Performance

Sisram Medical has current market cap of $137M, and enterprise value of $118M.

Market Cap Evolution


Sisram Medical's stock price is $0.29.

Sisram Medical share price increased by 1.3% in the last 30 days, and decreased by 62.4% in the last year.

Sisram Medical has an EPS (earnings per share) of $0.04.

See more trading valuation data for Sisram Medical
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$118M$137M0.0%1.3%-21.3%-62.4%$0.04

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Sisram Medical Valuation Multiples

Sisram Medical trades at 0.3x EV/Revenue multiple, and 3.2x EV/EBITDA.

See NTM and 2027E valuation multiples for Sisram Medical

EV / Revenue (LTM)


Sisram Medical Financial Valuation Multiples

As of July 19, 2026, Sisram Medical has market cap of $137M and EV of $118M.

Sisram Medical has a P/E ratio of 6.0x.

LTMLast FY202320242025202620272028
EV/Revenue0.3x0.3x0.3x0.3x0.3x
EV/EBITDA3.2x2.4x2.2x2.3x2.4x
EV/EBIT3.8x3.6x2.8x3.3x3.6x
EV/Gross Profit0.5x0.5x0.5x0.5x0.5x
P/E6.0x7.2x4.4x5.5x7.2x
EV/FCF-17.3x3.3x7.9x17.3x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Sisram Medical Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Sisram Medical Margins & Growth Rates

Sisram Medical grew revenue by 11% but EBITDA decreased by 33% in the last fiscal year.

In the most recent fiscal year, Sisram Medical reported gross margin of 59%, EBITDA margin of 13%, and net margin of 5%.

See estimated margins and future growth rates for Sisram Medical

Sisram Medical Margins

Last FY202420252026202720282029
Gross Margin59%62%59%58%
EBITDA Margin13%15%13%8%
EBIT Margin9%10%9%8%
Net Margin5%7%5%6%
FCF Margin2%4%2%-

Sisram Medical Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth11%(3%)5%11%
Gross Profit Growth9%(1%)(1%)9%
EBITDA Growth(33%)(2%)(6%)(33%)
EBIT Growth1%(15%)(9%)1%
Net Profit Growth37%(20%)(24%)37%
FCF Growth-(58%)(54%)-

Data powered by FactSet, Inc. and Morningstar, Inc.

Sisram Medical Operational KPIs

Sisram Medical's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.2M for the same period.

Sisram Medical's Rule of 40 is 19% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Sisram Medical's Rule of X is 35% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Sisram Medical
LTMLast FY202320242025202620272028
Rule of 4020%19%---
Bessemer Rule of X35%35%---
Revenue per Employee-$0.4M---
Opex per Employee-$0.2M---
S&M Expenses to Revenue35%35%35%38%35%
G&A Expenses to Revenue9%10%9%10%10%
R&D Expenses to Revenue4%5%5%5%5%
Opex to Revenue-50%49%52%50%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Sisram Medical Competitors

Sisram Medical competitors include Aroa Biosurgery, Curiosis, CVRx, EKF Diagnostics, Guerbet, Fractyl Health, C-Rad, Laxmi Dental, SDI Group and Fonar.

Most Sisram Medical public comparables operate across Medical Devices, DeepTech and HealthTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Aroa Biosurgery2.1x2.0x17.6x18.2x
Curiosis26.7x16.2x(29.3x)(64.4x)
CVRx2.1x1.9x(2.7x)(2.8x)
EKF Diagnostics1.9x1.8x7.6x7.4x
Guerbet0.5x0.5x4.7x4.7x
Fractyl Health--(1.4x)(1.5x)
C-Rad2.3x2.4x18.5x16.1x
Laxmi Dental4.0x3.8x24.4x23.1x

This data is available for Pro users. Sign up to see all Sisram Medical competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Sisram Medical

When was Sisram Medical founded?Sisram Medical was founded in 2013.
Where is Sisram Medical headquartered?Sisram Medical is headquartered in Israel.
How many employees does Sisram Medical have?As of today, Sisram Medical has over 1K employees.
Is Sisram Medical publicly listed?Yes, Sisram Medical is a public company listed on HKEX.
What is the stock symbol of Sisram Medical?Sisram Medical trades under 01696 ticker.
When did Sisram Medical go public?Sisram Medical went public in 2017.
Who are competitors of Sisram Medical?Sisram Medical main competitors include Aroa Biosurgery, Curiosis, CVRx, EKF Diagnostics, Guerbet, Fractyl Health, C-Rad, Laxmi Dental, SDI Group, Fonar.
What is the current market cap of Sisram Medical?Sisram Medical's current market cap is $137M.
What is the current revenue of Sisram Medical?Sisram Medical's last 12 months revenue is $387M.
What is the current revenue growth of Sisram Medical?Sisram Medical revenue growth (NTM/LTM) is 10%.
What is the current EV/Revenue multiple of Sisram Medical?Current revenue multiple of Sisram Medical is 0.3x.
What is the current EBITDA of Sisram Medical?Sisram Medical's last 12 months EBITDA is $37M.
What is Sisram Medical's EBITDA margin?Sisram Medical's last 12 months EBITDA margin is 9%.
What is the current EV/EBITDA multiple of Sisram Medical?Current EBITDA multiple of Sisram Medical is 3.2x.
How many companies Sisram Medical has acquired to date?Sisram Medical hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Sisram Medical has invested to date?Sisram Medical hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Sisram Medical

Lists including Sisram Medical

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial